Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay
Mohamed R. Elnagar, Anne B. Walls, Gouda K. Helal, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 106-113
Closed Access | Times Cited: 49

Showing 26-50 of 49 citing articles:

Computer aided drug discovery (CADD) of a thieno[2,3- d ]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2369-2391
Open Access | Times Cited: 9
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations
Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 4214-4233
Closed Access | Times Cited: 9
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2
Reda G. Yousef, Wagdy M. Eldehna, Alaa Elwan, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4079-4079
Open Access | Times Cited: 13
Cyclooxygenase-2 activates EGFR–ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia
Mohammed E. Abo‐El Fetoh, Maha M. Abdel‐Fattah, Wafaa R. Mohamed, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 499-516
Open Access | Times Cited: 13
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
Omnia R. Elbatrawy, Mohamed Hagras, Moshira A. El Deeb, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 966-966
Open Access | Times Cited: 7
Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of human α7 nicotinic acetylcholine receptor
Juan Facundo Chrestia, Ariana Bruzzone, María del Carmen Esandi, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 13, pp. 5381-5395
Open Access | Times Cited: 17
Glutamate blunts cell‐killing effects of neutrophils in tumor microenvironment
Tiantian Xiong, Ping He, Mi Zhou, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1955-1967
Open Access | Times Cited: 12
Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies
Nawaf A. Alsaif, Hazem A. Mahdy, Mohammed M. Alanazi, et al.
Archiv der Pharmazie (2021) Vol. 355, Iss. 2
Closed Access | Times Cited: 15
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation
Ahmed E. Azab, Mohamed S. Alesawy, Wagdy M. Eldehna, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Closed Access | Times Cited: 10
A novel thieno[2,3‐d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor‐2: A story of computer‐aided drug discovery
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1247-1265
Closed Access | Times Cited: 6
Discovery of New thieno[2,3- d ]pyrimidines as EGFR Tyrosine Kinase Inhibitors for Cancer Treatment
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 13, pp. 1167-1184
Open Access | Times Cited: 6
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Maju Mathew Koola
Human Psychopharmacology Clinical and Experimental (2020) Vol. 36, Iss. 1, pp. 1-16
Closed Access | Times Cited: 15
Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells
Patricia Sinclair, Nadine Kabbani
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0270479-e0270479
Open Access | Times Cited: 8
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers
Reda G. Yousef, Ibrahim H. Eissa, Hazem Elkady, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2583-2598
Open Access | Times Cited: 1
Demonstration of critical role of GRIN3A in nicotine dependence through both genetic association and molecular functional studies
Jiali Chen, Qiang Liu, Rongli Fan, et al.
Addiction Biology (2019) Vol. 25, Iss. 1
Closed Access | Times Cited: 10
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluation
Omnia R. Elbatrawy, Moshira A. El Deeb, Mohamed Hagras, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 12, pp. 1019-1035
Closed Access | Times Cited: 3
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, in vitro , and in silico studies
Reda G. Yousef, Ibrahim H. Eissa, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Open Access | Times Cited: 3
Probenecid ameliorates testosterone‐induced benign prostatic hyperplasia: Implications of PGE‐2 on ADAM‐17/EGFR/ERK1/2 signaling cascade
Maha M. Abdel‐Fattah, Mohammed E. Abo‐El Fetoh, Hassan Afify, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 2
Cinnamoyl-memantine hybrids: Synthesis, X-ray crystallography and biological activities
Maya Chochkova, Hailun Jiang, Radoslava Kyoseva, et al.
Journal of Molecular Structure (2021) Vol. 1234, pp. 130147-130147
Closed Access | Times Cited: 4
The human acetylcholinesterase c-terminal T30 peptide activates neural growth through an alpha 7 nicotinic acetylcholine receptor mTOR pathway
Alexandru Graur, Nadine Kabbani
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Activation of α7 Nicotinic Acetylcholine Receptor Improves Muscle Endurance by Upregulating Orosomucoid Expression and Glycogen Content in Mice
Fei Chen, Zhen Zhang, Huimin Zhang, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 9
Closed Access
The human acetylcholinesterase c-terminal T30 peptide activates neural growth through an alpha 7 nicotinic acetylcholine receptor mTOR pathway
Alexandru Graur, Patricia Sinclair, Nadine Kabbani
Research Square (Research Square) (2023)
Open Access
New thieno[2,3‐d]pyrimidine derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, antiproliferative activities, docking studies, ADMET, toxicity, MD simulation studies
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Journal of Heterocyclic Chemistry (2023) Vol. 61, Iss. 2, pp. 285-304
Closed Access
Effect of Compounds from Moringa oleifera Lam. on in Vitro Non‐Alcoholic Fatty Liver Disease (NAFLD) Model System
Motohiko Ukiya, Kazuki Motegi, Daisuke Sato, et al.
Chemistry & Biodiversity (2021) Vol. 18, Iss. 7
Closed Access
Previous Page - Page 2

Scroll to top